Scotiabank Boosts WELL Health Technologies (TSE:WELL) Price Target to C$7.00

WELL Health Technologies (TSE:WELL) had its price objective increased by analysts at Scotiabank from C$6.00 to C$7.00 in a report issued on Monday,BayStreet.CA reports. Scotiabank’s price target points to a potential downside of 1.27% from the company’s current price.

Several other research firms have also recently weighed in on WELL. Haywood Securities raised their price target on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday, December 13th. Ventum Financial lowered their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th. Finally, CIBC raised their price target on WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday, December 13th.

WELL Health Technologies Stock Up 1.4 %

Shares of TSE WELL opened at C$7.09 on Monday. WELL Health Technologies has a 52 week low of C$3.41 and a 52 week high of C$7.17. The business has a 50-day simple moving average of C$5.24 and a two-hundred day simple moving average of C$4.73. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. The company has a market cap of C$1.77 billion, a P/E ratio of 12.44, a P/E/G ratio of -1.93 and a beta of 1.20.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.